Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Closed
Phase 3
This trial is for people with non small cell lung cancer (NSCLC) that has spread. This is metastatic NSCLC. It means that the cancer has spread outside the lungs into the surrounding area. Or it has spread elsewhere in the body.
It is for people who have had treatment with and chemotherapy. Possible previous treatments include:
pembrolizumab
nivolumab
atezolizumab
durvalumab
and chemotherapy regimens with carboplatin or cisplatin
Recruitment start: 23 June 2019
Recruitment end: 15 February 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Samreen Ahmed
Merck Sharp & Dohme Ltd
Last reviewed: 18 February 2022
CRUK internal database number: 16541
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
